ECM
GSK icon

ExodusPoint Capital Management’s GSK GSK Stock Holding History

ExodusPoint Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,691
Closed -$850K – 1736
2025
Q3 		$850K Buy
+19,691
New +$769K 0.01% 1013
2024
Q2 		– Sell
-311,337
Closed -$13.3M – 1693
2024
Q1 		$13.3M Buy
311,337
+74,528
+31% +$3.07M 0.1% 163
2023
Q4 		$8.78M Sell
236,809
-62,488
-21% -$2.24M 0.06% 224
2023
Q3 		$10.8M Buy
299,297
+281,082
+1,543% +$9.98M 0.1% 203
2023
Q2 		$649K Buy
+18,215
New +$653K 0.01% 1260
2023
Q1 		– Sell
-280,187
Closed -$9.85M – 1898
2022
Q4 		$9.85M Buy
280,187
+30,029
+12% +$1M 0.14% 171
2022
Q3 		$7.36M Buy
250,158
+112,632
+82% +$4.27M 0.1% 285
2022
Q2 		$7.48M Buy
137,526
+113,010
+461% +$6.24M 0.09% 272
2022
Q1 		$1.33M Sell
24,516
-163
-0.7% -$8.85K 0.02% 980
2021
Q4 		$1.36M Sell
24,679
-7,321
-23% -$381K 0.01% 920
2021
Q3 		$1.53M Sell
32,000
-12,462
-28% -$626K 0.02% 844
2021
Q2 		$2.21M Buy
+44,462
New +$2.14M 0.02% 637
2021
Q1 		– Sell
-49,346
Closed -$2.27M – 2297
2020
Q4 		$2.27M Buy
49,346
+38,552
+357% +$1.77M 0.02% 498
2020
Q3 		$508K Buy
+10,794
New +$541K 0.01% 1008
2019
Q3 		– Sell
-5,040
Closed -$252K – 1450
2019
Q2 		$252K Sell
5,040
-10,500
-68% -$527K 0.01% 786
2019
Q1 		$812K Buy
+15,540
New +$777K 0.06% 226

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ExodusPoint Capital Management's GSK Position: Q4 2025 in Review

ExodusPoint Capital Management sold out of GSK (GSK) in Q4 2025, closing a stake of 19,691 shares — an estimated $850K sold.

ExodusPoint Capital Management first reported a position in GSK in Q1 2019 and held it in 16 quarters. The position peaked at $13.3M in Q1 2024. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

  • ExodusPoint Capital Management reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
  • ExodusPoint Capital Management sold 19,691 GSK shares in Q4 2025, an estimated $850K.
  • ExodusPoint Capital Management first reported a position in GSK in Q1 2019 and held it in 16 quarters.
  • ExodusPoint Capital Management's GSK position peaked at $13.3M in Q1 2024.
  • 995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.